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Purpose: This retrospective review describes urgical management of atherosclerotic 
renovascular disease (RVD) in hypertensive adults with diabetes mellitus. 
M.~thods: From July 1987 through July 1995, 54 consecutive hypertensive diabetics (mean 
21.3/103 mm Hg; mean medications three drugs) requiring either insulin (16 patients) or 
oral hypoglycemic therapy (38 patients ) had operative repair ofatherosclerotic KVD. Renal 
dysfunction (serum creatinine [SCr] >1.3 mg/dl)  was present in 82% of patients (mean 
SCr 2.4 mg/dl).  Associations between blood pressure and renal function response to 
operation and preoperative parameters were examined. Clinical characteristics, response to 
operation, and dialysis-free survival were compared with those of 291 nondiabetic 
patients. 
Results: Four (7.4%) operative deaths occurred. Among 50 survivors blood pressure 
response was considered cured or improved in 72% and unchanged in 28%. Of 42 patients 
with renal dysftmction 40% had improved function including three patients removed from 
dialysis. No preoperative parameter xamined emonstrated a significant association with 
blood pressure or renal function response. During follow-up 10 additional patient deaths 
occurred, and eight patients progressed to dialysis dependence. Time to death or dialysis 
was associated with preoperative estimates of glomerular filtration (p = 0.03) and the 
change in estimates of glomerular filtration after operation (p = 0.01). Compared with 
291 nondiabetics, the diabetic group had no statistical difference in improved function 
response (40% vs 51%, p = 0.21); however, diabetics had a significantly lower rate of 
beneficial blood pressure response (72% vs 89%, p = 0.01) and an increased risk of dialysis 
or death during follow-up (p = 0.02). By multivariate analysis independent predictors of 
time to death or dialysis included the presence of diabetes meUitus, patient age, history of 
congestive heart failure, and increased serum creatinine. 
Conclusions: Most of the selected iabetic patients had a beneficial blood pressure response 
after undergoing operative repair of atherosclerotic KVD, albeit at a lower rate compared 
with nondiabetics. In diabetics poor renal function before and after operation was 
associated with progression to dialysis and death. Improved renal function after operation 
was associated with improved survival; however, function response to renal revasculariza- 
tion was difficult to predict. (J Vasc Surg 1996;24:383-93.) 
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Despite the recognized contribution of elevated 
blood pressure to cardiovascular morbidity and mor- 
tality, the value of  surgical correction of atheroscle- 
rotic renovascular disease (RVD) in the diabetic 
remains uncertain. On the basis of a decreased rate of 
beneficial blood pressure response, early reports cited 
diabetes mellitus as a relative contraindication to 
operative renal artery repair. 1'2 Moreover, the results 
of surgical intervention to retrieve excretory renal 
function in the diabetic with renal insufficiency are 
often unpredictable, because the relative contribu- 
tions of RVD (i.e., ischemic nephropathy) and renal 
parenchymal disease (e.g., diabetic nephropathy) are 
poorly defined. 3'4 
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By contrast, we have not considered the presence 
of diabetes mellitus alone a contraindication to op- 
erativc correction of RVD. Given the uncertainties 
regarding surgical intervention i  this setting, how- 
ever, we have made a retrospective r view of operative 
management of atherosclerotic RVD in the diabetic 
to describe blood pressure and renal function re- 
sponse to surgery, to examine operative mortality and 
follow-up survival, and to compare these results with 
those of nondiabetic patients treated at our ccnter 
during the same period. Specific questions ofintcrcst 
included (1) the effect ofpreoperativc proteinuria on 
retrieval of renal function and (2) the impact of 
hypertension and renal function response on dialysis- 
free survival. 
MATERIAL AND METHODS 
Patient population. From July 1987 through 
June 1995, 428 hypertensive patients had operative 
repair of RVD at the Wake Forest University Medical 
Center. A subgroup of 54 consecutive adults with 
diabetes mellitus and atherosclerotic RVD are the 
topic of this report. This patient group included 37 
women and 17 men ranging in age from 52 to 78 years 
(mean 64 + 6 years). Each patient was hypertensive 
(mean blood pressure 213 + 29/103 + 21 mm Hg, 
mean medications three drugs), and each was consid- 
ered diabetic. Sixteen patients required insulin, and 
38 patients required oral agents for control of hyper- 
glycemia. Both groups had been treated from 3 to 24 
years (mean duration 12.6 years), and 11 patients had 
been diabetic for more than 10 years. No patient had 
received the diagnosis of diabetes mellitus before the 
fourth decade of life. 
The presence of significant extrarcnal atherosclc- 
rosis was determined from history, physical examina- 
tion, and results from preoperative evaluation (Table 
I). Extrarenal disease was considered present in 96% of 
all 54 patients. 
Renal dysfunction i dicated by a serum creatinine 
(SCr) >1.3 mg/dl off converting enzyme inhibitors 
and high-dose diuretics was present in 45 (82%) 
patients (mean SCr 2.4 mg/dl; 3 patients dialysis- 
dependent). On the basis of preoperative urinalysis 
from morning specimens, the presence of preopera- 
tive proteinuria was determined by dipstick (Clinitek 
Atias Analyzer, Miles, Inc., Elkhart, Ind.). Persistent 
proteinuria was present in 36 (67%) patients. Thirteen 
patients had trace to 30 mg/dl protein by dipstick 
urinalysis, whereas 23 patients had more than 100 
mg/dl. Seven patients had persistent proteinuria 
exceeding 300 mg/dl; each case had >3 gm protein 
from a 24-hour urine collection. In addition, three 
patients had received previous trcatment for diabetic 
retinopathy. Of these, urine protein determinations 
were negative (one patient) or had persistent pro- 
teinuria (100 mg/di; two patients). 
Patient treatment. After a complete medical 
history was taken and physical examination and rest- 
ing electrocardiography were performcd, 53 patients 
had additional cardiac evaluation. This evaluation 
included resting or stress echocardiography (43 pa- 
tients), exercise electrocardiography (20 patients), 
adenosine thallium scintigraphy (14 patients), and 
coronary angiography (I9 patients). Fifteen patients 
had had previous coronary artery bypass grafting. In 
eight instances this proccdure was performed within 4 
months of renal revascularization. 
Renal angiography was performed by either con- 
ventional (41 patients) or digital subtraction tech- 
nique (13 patients). By these techniques significant 
(___80% orificial stenosis or occlusion) unilateral ath- 
erosclerotic RVD was present in 22 patients, bilateral 
RVD was present in 28 patients, and 4 patients had 
significant disease to a solitary kidney. Twenty-two 
complete renal artery occlusions were observed in 21 
patients. An associated abdominal aortic aneurysm 
was demonstrated in ninc patients, whereas evere 
occlusive disease determined on angiography was 
considered present in 33 (61%) patients including 
seven complete aortic occlusions. 
Angiograms in 26 patients were adequate to grade 
the severity ofnephrosclerosis in 40 kidneys by criteria 
previously described, s In brief, these criteria consider 
cctasia ofintrarenal vessels, arterial volume, progres- 
sion of arterial branching pattern, and quality of 
nephrogram to estimate the kidney as normal (grade 
I), moderate (grade II), or severe (grade III) neph- 
rosclerosis. By these angiographic riteria grade I 
nephrosclerosis was present in 13% of kidneys, grade 
II was present in 40%, and grade III was considered 
present in 47%. 
Before the operation was performed, renal vein 
renin assays (RVRAs) or split renal function tests 
(SRFTs) were performcd in 18 patients. Lateraliza- 
tion (ratio >1.5:1) of renin activity or hyperconcen- 
tration ofnonreabsorbable solute was observed in 10 
of 13 patients with unilateral RVD and in three of five 
patients with bilateral disease. Renal revascularization 
was undertaken i  36 patients without preoperative 
tcsts of functional significance. These included four 
patients with a solitary kidney and 23 patients with 
equally severe bilateral disease. 
Operative procedures. Eighty-two kidneys un- 
derwent operation. Twenty-two patients had unilat- 
eral procedures for RVD, 28 had bilateral procedures, 
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Table I. Prevalence ofextrarenal atherosclerosis (n = 54 patients) 
No. of patients (%) Clinical manifestations No. of patients 
Cardiac 49 (91) Angina/MI 22 
CHF 17 
LVH 38 
CAB G/PTA 18 
Cerebrovascular 23 (43) TIA/CVA 17 
CEA 10 
Aortoiliac 42 (78) Severe occlusive disease 33 
Aortic occlusion 7 
Aortic anenrysm 9 
Infrainguinal 35 (65) Claudication 31 
PTA/Bypass 7 
MI, Myocardial infarction; LVH, left ventticular hypertrophy; CABG/PTA, coronary artery bypass grafting/percutaneous transluminal 
angioplasty; TIA/CVA, transient ischemic attack/cerebrovascnlar accident; CEA, carotid endarterectomy. 
and 4 patients had repair of a solitary kidney (Table 
II). Nine patients had contralateral nephrectomy for 
unreconstructible occlusive disease. These kidneys 
averaged 7.8 cm in length (range 6.3 to 8.1 cm). 
Renal artery reconstruction i cluded aortorenal by- 
pass in 36 instances (29 saphenous vein, 7 polytet- 
rafluoroethylene) and reimplantation i 10 instances. 
Twenty-seven renal artery endarterectomies were 
performed by either transrenal (17 instances) or 
transaortic (I0 instances) technique. In no instance 
was significant RVD (i.e., >80% stenosis) left un- 
treated. 
Simultaneous aortic reconstruction was required 
in 21 (39%) patients. Nine patients required com- 
bined repair of an abdominal aortic aneurysm (four 
tube, five Y grafts), whereas 12 patients had repair of 
clinically significant aortic occlusive disease. Among 
these combined procedures 13 patients had bilateral 
renal artery reconstruction. 
Statistical methods and analysis. Values of se- 
rum creatinine were transformed to a calculated 
measure of estimated glomerular filtration rate 
(EGFR, ml /min/1 .73m 2) with the modified formula 
of Cockroft and Gault: 6 
(140 - Age) (Weight) 1.73 
EGFR = x - -  (72) (Serum Creatinine) BSA 
where body surface area (BSA) was calculated by 
BSA = [Height (cm)]  °725 X [Weight (kg)] °4 25 x 
0.007184. For female patients EGFRwas multiplied 
by 0.85 to correct for gender differences in muscle 
mass and average rate of creatinine synthesis. 
Summary statistics (i.e., means, SD of continuous 
data and frequencies and relative frequencies of cat- 
egoric data) were calculated, and the data were 
examined to verify that assumptions of statistical tests 
were met. In patients preoperative r nal insufficiency 
(i.e., SCr _>1.3 rag/all) analysis of differences in mean 
Table II. Summary of operative procedures 
Me@od No. 
36 Aortorenal bypass 
Vein 
Polytetrafluoroethylene 
Branch repairs 
Reimplantation 
Endarterectomy 
Transrenal 
Transaortic 
Contralateral nephrectomy 
Total 
29 
7 
17 
10 
10 
27 
9 
82 
preoperative EGFR for unilateral versus bilateral re- 
pair was performed with an unpaired t test, analyses of 
postoperative change in EGFR for each group were 
performed with unpaired t tests, and analysis of 
differences in mean postoperative EGFR between 
groups was performed with analysis-of-covariance 
that controlled for preoperative EGFR levels. Asso- 
ciations of nephrosclerosis (graded I, II, or III) and 
proteinuria (graded 0, 15, 30, 100, or 300) with 
preoperative and postoperative EGFR levels were 
assessed with Spearman's rank correlation. 7 Associa- 
tions between bilateral repair and preoperative and 
postoperative EGFR in all diabetic patients were 
assessed with Pearson product-moment correlations. 
Comparison of demographic factors between diabetic 
and nondiabetic patient groups was performed with 
Z2 tests or unpaired t tests. 
Graphic depiction of overall postoperative dialy- 
sis-free survival used product-limit estimates of the 
survival distributions for diabetics and nondiabetics. 
Graphic depiction of the influence of renal function 
response on dialysis-free survival in diabetic patients 
used predicted time to dialysis or death from a 
proportional hazards regression model 8 so that 
change in EGFR could be used as a continuous 
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predictive factor. Tests for associations between fac- 
tors of interest and dialysis-free survival were per- 
formed with proportional hazards regression models. 
A "best" subset of factors to predict postoperative 
dialysis or death in diabetics and nondiabetics com- 
bined was selected with a backwards elimination 
model selection procedure, 9 where the following 
factors were included in an initial model: diabetes 
status, age, history of left ventricular hypertrophy, 
history of congestive heart failure, history of coronary 
artery bypass grafting, history of myocardial infarc- 
tion or angina, history of transient ischemic attack or 
cerebrovascular accident, preoperative s rum creati- 
nine, preoperative aortic aneurysm or occlusive dis- 
ease, and patient sex. Factors were eliminated one-by- 
one starting with the least significant, and hazard ratio 
parameters and their tests of significance were esti- 
mated at each step until only factors ignificant at the 
10% s-level remained in the model. 
RESULTS 
Operative morbidity and mortality 
Early events. After surgery was performed, four 
patients died in the hospital or within 30 days of 
operation (Table III), producing a mortality rate of 
7.4%. Operative mortality was influenced by the 
complexity of surgical repair. Three of four deaths 
occurred after bilateral procedures for RVD com- 
bined with aortic replacement were performed. The 
fourth death resulted from hepatic failure after epair 
of a symptomatic renal artery aneurysm was per- 
formed in a patient with lcnown cirrhosis. Considering 
operative mortality and extent of surgical repair, when 
the surgical procedure was limited to renal artery 
reconstruction, one perioperative d ath was observed 
among 33 patients (3% mortality), but when renal 
artery reconstruction was combined with aortic re- 
construction in 21 patients, three perioperative 
deaths occurred (i4% mortality). 
Morbid events that prolonged hospital stay oc- 
curred in 13 (26%) patients. These included pneumo- 
nia (two patients), prolonged (>5 days) mechanical 
ventilatory support (one patient), serious arrhythmia 
(four patients), unstable angina (one patient), cere- 
brovascular ccident (one patient), peripheral thero- 
embolism (two patients), and wound infection (two 
patients). Four patients had a significant (i.e., >20%) 
increase in SCr. Three of these patients required 
temporary dialysis support before discharge. 
Late events. During a mean follow-up of 32.6 
months 10 additional deaths occurred. Cardiovascu- 
lar events accounted for 90% of follow-up mortality. 
Myocardial infarction (three patients), congestive 
heart failure (one patient), or cerebrovascular cci- 
dent (one patient) were responsible for five late 
deaths. A cardiovascular cause was presumed in four 
sudden follow-up deaths. Gastrointestinal b eeding 
accounted for the single noncardiovascular death. 
Nonfatal cardiovascular events occurred in nine 
(18%) patients, whereas eight (16%) patients pro- 
gressed to dialysis dependence on follow-up. Cardio- 
vascular events included myocardial infarction (two 
patients), congestive heart failure (two patients), 
cerebrovascular ccident (three patients), or lower 
extremity ischemia (two patients). One patient re- 
quired reoperation for a small bowel obstruction. 
Additional vascular econstruction was required in 
five patients and included femoropopliteal bypass 
(two patients), aortobifemoral bypass (one patient), 
coronary artery bypass (one patient), and renal artery 
bypass (one patient). Overall 46 (92%) patients had 
patency of the renal reconstruction determined by 
either angiography or renal duplex evaluation. In 
three (4.1%) instances a renal artery repair underwent 
thrombosis, and one contralateral native renal artery 
had stenosis on follow-up. 
The product-limit estimate of time to dialysis 
dependence or death for diabetic patients is depicted 
by the solid line in Fig. 1. Preoperative EGFR was 
significantly and inversely associated with time to 
dialysis or death on follow-up (p = 0.03). Although 
hypertension response did not demonstrate a signifi- 
cant association with dialysis dependence or fol- 
low-up death, renal function response to operation 
was important. Diabetic patients who had improved 
renal function after operation had a significantly 
decreased risk of death or dialysis compared with 
patients who were unchanged or worsened (Fig. 2, 
p = 0.01). 
Blood pressure response. Blood pressure and 
antihypertensive medication requirements at least 8 
weeks after operation were used to define blood 
pressure response to operation. A patient was consid- 
ered cured when he or she had a diastolic blood 
pressure of<90 mm Hg while recciving no antihyper- 
tensive therapy. Patients were considered improved if
they met the following criteria: (I) diastolic pressures 
were controlled (i.e., <90 mm Hg) before surgery, 
medication requirements to achieve control must 
have been reduced by at least wo drugs, (2) for those 
patients whose blood pressures were not controlled 
before surgery and who had a decrease in diastolic 
pressure of<20 mm Hg associated with postoperative 
control, medication requiremcnts must have been 
reduced by at least one drug, and (3) control of blood 
pressure with decrease in diastolic pressure _>20 mm 
Hg on no more medication than before surgery. 
Patients not meeting these criteria for cured or 
improved were categorized as failed. 
When these criteria are applied to the 50 patients 
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Fig. 1. Product-limit estimates of time to death or dialysis for diabetics (solid line) and 
nondiabetics (broken line) after operative renal artery repair. 
Table I I I .  Summary of operative deaths 
Sex Age Insulin required Aortic disease Operation Cause of death 
F 78 No AAA Bilateral RAB Cardiac arrest 
AFBG MSOF 
M 79 Yes AAA Bilateral RAE Uremia 
AFBG 
F 66 No OCCL Bilateral RAE Perforated ulcer 
AFBG MSOF 
F 67 No OCCL Ex Vivo RAB Hepatic failure 
F, Female; M, male; AAA, abdominal aortic aneurysm; OCCL, occlusive disease; RAB, renal artery bypass; RAE, renal artery 
endarterectomy; AFBG, aortobifemoral bypass grafting; MSOF, multisystem organ failure. 
surviving operation, 2 (4%) patients were considered 
cured, 34 (68%) patients were improved, and 14 
(28%) patients were classified as failed. 
Blood pressure response demonstrated nosignifi- 
cant association with patient age, duration of hyper- 
tension or diabetes, or requirement for insulin. 
Among patients with preoperative RVRAs or SRFTs, 
unilateral repair in 7 of 10 patients with lateralizing 
studies was associated with a favorable blood pressure 
response (0 cured, 7 improved). One of three patients 
with unilateral repair and nonlateralizing studies was 
considered improved. Among 14 patients classified as 
having a failed blood pressure response, 12 had 
nonlateralizing studies (2 patients) or empiric repair 
without functional tests (10 patients). 
Renal[ function response. A significant change in 
excretory renal function was defined as a change in 
SCr of >_ 20% obtained at least 3 weeks after opera- 
tion. Patients were considered improved if they were 
removed from dialysis or if their SCr decreased by at 
least 20%. Patients were classified as worsened if SCr 
increased by 20% or more. All others were considered 
to have no change. When the 42 patients who 
survived operation and who had a preoperative SCr of 
_>1.3 mg/d l  are considered, these criteria classified 17 
(40%) patients improved including 3 removed from 
dialysis, 18 (43%) patients no change, and 7 (17%) 
patients worsened. One patient with an SCr of <1.3 
mg/d l  was temporarily worsened 3 weeks after 
surgery. 
The increase in postoperative EGFR for patients 
considered improved was significantly greater than 
that for patients considered unchanged or worsened 
(p = <0.01 ). When individual patients are considered, 
however, change in EGFR demonstrated no signifi- 
cant relationship to the site of disease or extent of 
operation (Tables IV and V). Similarly, neither the 
duration of diabetes mellitus, presence or degree of 
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(broken line) renal function after operative renal artery repair. 
Table IV. Renal function response versus ite of disease (n = 42) 
Change in SCr* 
Unilateral (n = 17) 
Percent (Mean A in EGFR + SE) 
Bilateral (n = 25) 
Percent (Mean A in EGFR + SE) 
Improved 41 (20.1 + 5.5) 40 (12.4 + 2.9) 
No change 53 (-1.6 + 2.9) 36 (0.0 + 1.9) 
Worsened 6 (-28.9 _+ --)  24 (-15.5 + 4.2) 
*Significant change _>20% SCr. 
preoperative proteinuria, nor the angiographic grade 
of nephrosclerosis was significantly associated with 
change in EGFR after operation (Table VI). 
Of the eight patients progressing to dialysis during 
follow-up (mean preoperative SCr 3.4 mg/dl), seven 
had either no change (five patients) or worsened (two 
patients) renal function after operation. The eighth 
patient was initially removed from dialysis depen- 
dence but returned to dialysis 20 months after surgery 
(postoperative EGFR 12.2 ml/min/1.73m2). For 
each patient progressing to dialysis, patency of renal 
artery repair was demonstrated by renal duplex 
sonography. In contrast o change in EGFR after 
operation, neither preoperative proteinuria nor hy- 
pertension response predicted eventual dialysis de- 
pendence. Among the seven patients with proteinuria 
>300 mg/dl and ->3 gm protein from 24-hour urine 
collection (mean preoperative SCr 2.3 mg/dl), one 
operative death occurred. Among the six patients who 
survived operation, renal function was considered 
improved in three and unchanged in three. 
Tables VII and VIII compare the demographic 
features and results of surgical treatment for these 54 
diabetic patients with those of 291 hypertensive 
nondiabetic adults operated for atherosclerotic RVD 
during the same time period. Significant differences 
existed between diabetic and nondiabetic patients 
regarding sex distribution, mean age, preoperative 
blood pressure, and prevalence of end-organ disease. 
Specifically, diabetics had a significantly greater preva- 
lence of ischemic heart disease and congestive heart 
failure, cerebrovascular disease, and renal insuffi- 
ciency (Table VII). 
After renal artery repair was performed, diabetics 
had an operative mortality more than double (7.4%) 
that of nondiabetics (3.1%); however, this difference 
did not reach statistical significance (Table VIII, 
p= 0.13). Likewise, no significant difference was 
observed in improved renal function response be- 
tween the two groups (40% vs 51%, p = 0.21); how- 
ever, significantly fewer diabetics had a beneficial 
blood pressure response after renal artery repair 
compared with nondiabetics (72% vs 89% cured or 
improved, p = <0.01). 
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Table V. Change in EGFR versus ite of operation (n = 42) 
No. of patients Preoperative EGFR (mean + SE) Postoperative EGER (mean + SE) * 
Unilateral 17 35.0 + 3.1 < p = 0.20 ) 38.9 ± 3.8 
p = 0.45 p = 0.36 
25 31.8-+2.6 < - p=0.65  ) 34.3±3.1 Bilateral 
* Postoperative EGFR and test for differences calculated after controlling for preoperative EGFR levels. 
Table VL Correlation between EGFR and selected preoperative parameters 
Preoperative EGFR 
.Parameter Mean SE Correlation 95% CI 
Change in EGFR 
Correlation 95% CI p 
Severity of nephrosclerosis* 2.33 0.13 -0.32 
Proteinuria* 14.6 7.9 -0.28 
Bilateral reconstruction t 0.59 0.07 -0.28 
(-0.72, 0.08) (-0.69, 0.13) -0.28 0.18 
(-0.55, -0.01) (-0.22, 0.35) 0.06 0.67 
(-0.51,-0.01) (-0.44, 0.10) -0.19 0.74 
CI, Confidence interval. 
*Spearman rank correlation. 
1"Pearson product-moment correlation. 
The product-limit estimates of time to death or 
dialysis dependence for diabetics and nondiabetics are 
compared in Fig. 1. Diabetics had a significantly 
greater isk of death or dialysis on follow-up com- 
pared with nondiabetics (p= 0.02). When all patients 
are considered, multivariate analysis demonstrated 
that the presence of diabetes mellitus, advanced 
patient age, history of congestive heart failure, and 
increased serum creatinine before surgery were sig- 
nificantly and independently associated with fol- 
low-up dialysis dependence and death (Table IX). 
DISCUSSION 
Is surgical correction of atherosclerotic RVD in 
the hypertensive diabetic worthwhile? Unfortunately, 
this retrospective r view does not answer this ques- 
tion conclusively. Although most of the selected 
diabetic patients had beneficial blood pressure re- 
sponse after operation, significantly fewer diabetics 
were cured or improved compared with nondiabetics. 
Renal function response was not statistically different 
for diabetics when compared with that of nondiabet- 
ics, but function response in the diabetic was unpre- 
dictable. Neither the site of disease, operation, nor 
grade of nephrosclerosis was associated with renal 
function response in the diabetic. In addition, the 
presence and level of preoperative proteinuria f iled to 
demonstrate an association with excretory function 
either before or after enal revascularization. 
Despite the issues unresolved by this experience, 
the question of intervention for RVD in the diabetic 
has practical importance. Previous studies suggest 
that adult diabetics have an increased prevalence of 
atherosclerotic RVD and an increased risk of bilateral 
RVD compared with nondiabetics. ~°'n Additional 
cpidemiologic data suggest hat hypertension may 
occur twice as frequently in diabetics compared with 
nondiabetics. 12 Although the functional relationship 
between hypertension and renal artery lesions has 
rarely been defined in previous reports, at least 2.5 
million Americans have both hypertension and dia- 
betes mellitus. 1,u-13 Given these circumstantial data, 
we believe that RVD may contribute to hypertension 
in a larger proportion of diabetics than is commonly 
recognized. Moreover, elevated blood pressure has 
bccn associated with increased cardiovascular risk in 
virtually all population-based studies to date; how- 
ever, hypertension in the diabetic population appears 
to contribute disproportionately to adverse cardiovas- 
cular events, accelerated retinopathy, and renal dys- 
function. 12 
In addition to contributing to accelerated renal 
dysfunction through renovascular hypertension, data 
suggest hat RVD may contribute directly to end- 
stage renal disease through ischemic nephropathyY 4 
In this regard we have recently used renal duplex 
sonography to define the prevalence of RVD and 
ischemic ncphropathy in adults evaluated for renal 
replacement therapy in our center. 15 Of 45 consecu- 
tive patients 49% had diabetes mellitus, and overall 
RVD was detected by renal duplex sonography in 10 
of 45 patients tudied. In each instance RVD was 
observed in white but not black participants. When 
onlywhite patients are considered, 10 (40%) of 25 had 
RVD, whereas 5 had bilateral renal artery disease. 
Ischemic nephropathy was present in two of five white 
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Table VII. Comparison of diabetic and nondiabetic patients 
Parameter Diabetic (n = 54) Nondiabetic (n = 291) p 
Sex 
Malc 17 143 0.02 
Female 37 148 
Age (yr + SD) 
Mean 64 + 6.0 61 + 10.9 0.01 
Range 52-78 40-86 
Mean blood pressure 213 _+ 29/103 + 21 202 _+ 29/109 + 22 0.03* 
Duration hypertension (yr) 12.6 10.0 0.08 
Cardiac (%) 
Angina/MI 66.7 37.3 0.01 
CHF 31.5 17.9 0.02 
Cerebrovascular (%) 
TIA/CVA 31.5 18.0 0.02 
CEA 18.5 13.8 0.36 
Renal (%) 
SCr _>1.3 82 64 0.01 
Preoperative dialysis 3.7 7.9 0.27 
Aortic (%) 
AAA 5.6 6.2 0.86 
Occlusive 72.2 56.3 0.03 
MI, Myocardial infarction; CHF, congestive heart failure; TIA, transient ischemic attack; CVA, cerebrovascular accident; 
endarterectomy; SCr, serum creatinine; AAA, abdominal aortic aneurysm. 
*p Value for systolic pressure only. 
Table VII I .  Comparison of operative results between diabetic and nondiabetic patients 
CEA, carotid 
Diabetic (n = 54) Nondiabetic (n = 291) p 
7.4 3.1 Perioperative mortality (%) 
Hypertension response (%)* 
Cured 9 13 
Improved 63 76 
No change 28 11 
Renal function response (%)* (preoperative SCr _>1.3 mg/dl) 
Improved 40 51 
No change 43 34 
Worsened 17 15 
0.13t 
0.01¢ 
0.21¢ 
*See text for definition. 
i'Fischcr's exact est. 
¢%2 test. 
diabetics, and both of these patients had bilateral renal 
artery stenosis. Although the number of patients 
examined issmall, this prospective study suggests that 
RVD may contribute to renal insufficiency in a sig- 
nificant minority of diabetic adults reaching end-stage 
renal disease. 
The importance of this observation is demon- 
strated by our experience with operative management 
of dialysis-dependent ischemic nephropathy.S To date 
we have surgically corrected RVD in 26 patients 
considered permanently dialysis-dependent. Twenty- 
one patients were initially removed from dialysis, and 
19 (73%) have remained ialysis-independent during 
follow-up. Of  note, three of these patients were 
diabetic, and all were initially removed from dialysis. 
Besides the improved quality of life conferred by 
retrieval of renal function, patients removed from 
• dialysis dependence have had significant improve- 
ment in estimated survival. Moreover, diabetics with 
renal insufficiency who have improved excretory renal 
function after operation have a significant decrease in 
predicted eath and dialysis dependence during fol- 
low-up. 
Given the potential contribution of RVD to re- 
versible renal insufficiency among diabetics, our in- 
ability to define predictors of renal function response 
in these patients was disappointing. Preoperative 
parameters that have demonstrated significant asso- 
ciation with function response in other patients failed 
to demonstrate significance in the diabetic. In the 
nondiabetic we have observed a significant association 
between increased EGFR after operation and site of 
disease, extent of operation, angiographic grade of 
nephrosclerosis, and rate of preoperative decline in 
renal function, sJ4'16 All but one parameter were 
examined in the diabetic group and were found to 
have no significant association with postoperative 
EGFR. Unfortunately, too few serial measures of 
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Table IX. Results of proportional hazards regression model of time to dialysis or death 
Variable f3 coefficient SE (~3) Hazard ratio 95% CI p 
Diabetes 0.6702 0.2804 1.96 (1.13, 3.39) 0.02 
Age (10-yr increments) 0.6177 0.1738 1.85 (1.32, 2.60) <0.01 
History of congestive heart failure 0.8288 0.2666 2.29 (1.36, 3.86) <0.01 
Preoperative s rum creatinine 0.6040 0.1320 1.90 (1.46, 2.46) <0.01 
All variables significant at s-level 0.10 included. 
CI, Confidence interval. 
preoperative s rum creatinine were available to esti- 
mate the mean rate of function decline for our diabetic 
patients. Because function decline associated with 
intrinsic renal disease isgenerally inear over time, and 
decline observed in ischemic nephropathy is nega- 
tively dec, elerated, a difference in the rate of decline 
might be expected between those diabetics with 
improved renal function compared with those un- 
changed or worsened after operation) *,x7 
In particular, the absence of a significant relation- 
ship between preoperative proteinuria and renal func- 
tion response was unexpected. Although urine pro- 
tein may have many sources, proteinuria s a hallmark 
manifestation f diabetic glomerulopathy, is Despite 
this fact the presence and level of proteinuria in our 
diabetic patients did not correlate with renal function 
either before or after operation. Retrieval of renal 
function was equivalent for patients without detect- 
able levels of urine protein and for patients with heavy 
proteinuria. Possible explanations for this finding 
include the presence of microproteinuria undetected 
by our method of protein assay. 18'19 In this instance 
patients considered negative for protein would have 
protein at levels below 15 mg/dl when more sensitive 
methods of detection were applied) 9Alternatively, 
the glomerular p ocess responsible for filtered protein 
may not occur uniformly throughout the kidney) 8
This variability may provide heavy proteinuria from 
diseased glomeruli, whereas undiseased glomeruli 
and their nephron units provide improved excretory 
function after renal revascularization. Finally, low 
levels of urine protein are frequently observed in 
patients with both essential and renovascular hyper- 
tension. 2° In the case of RVD heavy proteinuria has 
been observed, resulting from an activated renin- 
angiotensin system that resolved after nephrectomy? ~ 
This mechanism for proteinuria seems unlikely in our 
diabetic group, however, because levels of urine 
protein before and after surgery did not differ egard- 
less of the hypertension response to operation. 
Last, the operative mortality observed in this 
group of diabetic patients deserves comment. Al- 
though the 7.4% overall mortality rate did not differ 
significantly from that of nondiabetics, operative 
mortality increased with the extent and complexity of 
procedure. 16A 14% operative mortality rate was 
observed in diabetics after enal reconstruction com- 
bined with aortic repair was performed. This opera- 
rive mortality rate was observed espite aggressive 
cardiac evaluation and intense cardiovascular manage- 
ment after surgery. The low absolute number of 
deaths precluded efinition of significant risk factors 
for operative mortality; however, we believe these 
data support a conservative approach to clinically 
silent aortic or renal disease. In both diabetics and 
nondiabetics we undertake renal reconstruction i  
combination with aortic repair only for clinically 
important disease at both sites. 
In summary, our experience in patients treated for 
atherosclerotic RVD suggests that diabetics differ in 
many respects from nondiabetics. In addition to sig- 
nificant demographic differences, diabetics had a sig- 
nificantly decreased rate of beneficial blood pressure 
response after surgery. Although the rate of improved 
renal function did not differ statistically, predictors of 
function response significant for nondiabetics did not 
apply to the diabetic group. Moreover, diabetics had a 
significant and independent risk of follow-up death or 
dialysis that was associated with unimproved renal 
function after operation. Rather than view diabetes as 
a contraindication for renovascular repair, the pres- 
ence of diabetes mellitus hould be considered incon- 
text of other independent predictors of increased 
follow-up mortality. In the absence of accurate pre- 
dictors of renal function response, the elderly diabetic 
with congestive heart failure and azotemia may be 
best served by nonoperative treatment. 
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DISCUSSION 
Dr, Mitchell H. Goldman (Knoxville, Tenn.). First, I 
would likc to congratulate Dr. Hanscn and his coworkers for 
an excellent article and presentation and to thank Dr. 
Hansen for providing me with a number of reprints in a truly 
timely fashion. I got the opportunity to watch the evolution 
of his article, which is a wonderful treat. 
This work represents a continuation of the extensive 
experience of Dr. Hansen and his group in the area of 
renovascular hypertension. It confirms that in patients with 
diabetes mellitus, especially type II diabetes mellitus, re- 
novascular hypertension may bc an adjunctive cause of 
hypertension a d loss of renal function. It also demonstrates 
that although diabetes i not a contraindication to repair, it 
is associated with ~ncreased mortality, poorer functional 
result, and increased long-term morbidity and mortality. 
Improved function and decreased hypertension may 
ensue in diabetics with renovascular disease having a repair, 
albeit with a higher mortality rate and less extensive 
improvement when compared with a historic ontrol group 
of nondiabetic atherosclerotic patients undergoing repair 
for renovascular hypertension alone. Although the two 
groups are similar, one critique of the study is that thc 
diabetic group is both older and in almost every criterion for 
atherosclcrosis is icker. These two factors kew the mortal- 
ity data, especially the long-term mortality. I would ask Dr. 
Hansen why the return to dialysis morbidity and latc 
mortality were linked? Is the long-term mortality alone 
different between the atherosclerotic and the diabetic 
population? 
Dr. Hansen reports that no preopcrative tests for 
nephrosclerosis were predictive of a change in renal function 
after bypass. I would ask about the sensitivity of the tests 
used: arteriography, serum creatinine, EGFR, and pro- 
teinuria by dipstick alone. The latter test can be affected by 
blood sugar, degree of blood pressure control, and angio- 
tensin-converting enzyme inhibitors for a start. EGFR is at 
best as variable as the daily creatinine, and small changes in 
creatinine with the equation may be magnified by the 
equation for EGFI~ Arteriography is highly subjective, and 
although the group has found it to be worthwhile in 
atherosclerotics, it may not adequately reflect the subtle 
degree ofglomerulopathy in diabetics, and glomerulopathy 
is the entity that ultimately finishes the diabetic kidney. 
Were any of the diabetic patients ubjected to renal 
biopsy? Mso, is insulin requiring diabetes mellitus the same 
as that controlled by oral hypoglycemics, or does it simply 
reflect how tightly controlled the patients are kept by their 
physicians? Perhaps hemoglobin A2 would be helpful in 
predicting the extent of glomerular disease and the subse- 
quent response in renal function. Does the duration of 
diabetes alone make a difference? 
I always have a bit of trouble with the "improved" 
categories in hypertension studies. Because all antihyper- 
tensives are not created equal--and recently we are finding 
out that calcium channel blockers that were considered 
relatively benign medications had their own nonbenign 
sequelae--especially in the .method of action and potency, 
using the absolute number ofantihypertensive drugs given 
in a highly subjective way for me has always been a little bit 
troubling. Does improvement with the three categories you 
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enumerated make a long-term difference in survival and 
function? kaad is there a difference among each group with 
the different criteria in the context of long-term survival in 
renal function? 
Dr. Hansen's group, in a wonderful discussion, and I 
commend !it to your reading, confirms another important 
finding previously reported. Operations for renovascular 
disease coupled with aortic repair has an increased risk and 
should be approached quite selectively. 
Dr. H~msen. Thank you, Dr. Goldman, for those kind 
comments and your questions. Regarding accelerated death 
in the dialysis-dependent group, I think our group and 
others have demonstrated a clear-cut increase in follow-up 
death among atherosclerotics admitted to dialysis. The 
group from Cornell has described a median survival of only 
27 months among those who have ischemic nephropathy as
a basis for their renal insufficiency. The follow-up mortality 
of the diabetic is increased and likely is caused by the 
associated cardiovascular disease. It is interesting, though, 
that in those diabetics who have improved function, their 
predicted survival is equivalent to those patients who are not 
diabetic, so renal function response appears to convey 
improved protection from dialysis dependence and survival. 
We would agree that the sensitivity of the predictors that 
we examined is poor. We tried to use first-morning urine 
samples for proteinuria to limit the variability of volume 
status. The technique does not detect microproteinuria. 
Our use of a calculated measure of estimated glomerular 
filtration has definite limitations, as does the use of a 
calculated creatinine clearance to estimate glomerular fil- 
tration rate. What we have attempted to do with the 
calculated measure of filtration is to control for those 
parameters that are known to most influence serum creati- 
nine as an endogenous analyte of renal function: patient age, 
size, and sex. Whether the angiographic anatomy that is 
depicted on diagnostic studies that examine intrarenal 
vessels has a clear-cut correlation with nephrosclerosis is not 
known. We do not have histologic confirmation. It is 
interesting that other studies that have looked at the 
combination of main renal artery disease and arteriolar 
sclerosis find a positive correlation. 
We do not have renal biopsy results in this group, but we 
do have results from nine nephrectomies. Unfortunately, 
we did not have angiographic data for comparison with 
those nine patients. Four of nine nephrectomies demon- 
strated mild changes consistent with diabetic renal disease. 
The remainder had hypertensive n phrosclerosis. 
All of these patients should be considered type II 
diabetics, although 16 required insulin. I think these latter 
patients had poor weight control and other medical man- 
agement features that required insulin, but none were type 
I diabetics. We had no hemoglobin A2 levels for compari- 
son. The duration of diabetes was examined and played no 
role in the hypertension or function results in this patient 
group. 
We thought hat hypertension response would play a 
role in patient survival. Hypertension i  diabetics plays a 
disproportionate role in renal dysfunction. It is the most 
important accelerate of diabetic nephropathy and of reti- 
nopathy, and it plays a disproportionate role in adverse 
cardiovascular events; however, we did not observe an 
association between hypertension improvement and sur- 
vival. 
The operative mortality observed in this group is 
sobering, and it serves to reinforce our policy of restricting 
the repair of aortic disease in combination with renal disease 
for clinically significant disease at both sites. 
The question posed in our title is unanswered. I think 
that the presence of diabetes mellitus would have to be 
considered along with other preoperative measures of 
patient status, particularly when it occurs in combination 
with elevated serum creatinine proceeded by a long linear 
decline in renal function and congestive heart failure in a 
patient with advanced age. In those patients we may best 
avoid surgery. 
Dr. Francis Robicsek (Charlotte, N.C.). Do you have 
any control group of patients who underwent renal artery 
stenting in your institution? What about a medically treated 
group? With 40% of patients unchanged, 17% worse, and 7% 
dead, I think you are on the verge of saying we should not 
operate on these patients. How do the same patients fair if 
they are treated medically? Do you plan to do a prospective, 
maybe randomized, study? 
Dr. Hansen. There is no control group. This entire 
diabetic group had ostial aortic atherosclerosis. None was 
treated by angioplasty or stent preliminary to operation. In 
the patient on whom we operate and in whom we do not 
improve renal function, it is very difficult to demonstrate 
that we have helped that patient. Our greatest need is to 
identify those predictors that will allow us to identify the 
patient who will have improved renal function after inter- 
vention. To this point we have operated on the premise that 
the patient fraction improved has improved dialysis-free 
survival conveyed by operation and justified our interven- 
tion on that basis. 
